发明名称 Continuous, normal human t-lymphocyte cell lines comprising a recombinant immune receptor with defined antigen specificity
摘要 The invention describes continuously growing, normal T-lymphocyte cell lines (T-lymphocyte lines) comprising nucleic acids sequences encoding immune receptors, for example T-cell receptors, with defined antigen specificity, wherein the nucleotide sequences are operably linked to an expression signal not natively associated therewith. Further, this invention is directed to methods of adoptive immunotherapy. In particular methods for allogeneic adoptive immunotherapy are provided. This invention further relates to methods for adoptive immunotherapy in the treatment of cancer in a human being, including therapy of malignant melanoma. Moreover this invention relates to methods for cultivating unlimited amounts of activated T-lymphocytes stably expressing a T-cell receptor with defined tumour antigen specificity and reactivity.
申请公布号 US2004260061(A1) 申请公布日期 2004.12.23
申请号 US20030471481 申请日期 2003.12.15
申请人 KALTOFT KELD 发明人 KALTOFT KELD
分类号 A61K35/12;A61K39/00;A61K48/00;C12N5/0783;(IPC1-7):C12N5/08;C07K14/705 主分类号 A61K35/12
代理机构 代理人
主权项
地址